A randomized, evaluator-blinded, parallel group, comparator-controlled, multicenter study to evaluate the safety and effectiveness of GP0112 for cheek augmentation and correction of midface contour deficiencies | Vince Bertucci, MD, FRCPC: Bertucci MedSpa

Vince Bertucci, MD, FRCPC: Bertucci MedSpa
8333 Weston Road, Suite 100
Woodbridge, ON L4L 8E2
Phone: (905) 850-4415
Hours: Monday: 8 a.m.–5 p.m.
Tuesday: 9 a.m.–5 p.m.
Wednesday – Thursday: 8 a.m.–5 p.m.
Friday: 8 a.m.–4 p.m.

Concluded: 2024

Evaluating the safety and effectiveness of GP0112 dermal filler for cheek augmentation and correction of midface contour deficiencies

This study evaluated the non-inferiority of GP0112, a dermal filler, versus a comparator-control in cheek augmentation and correction of midface contour deficiencies.